Effects of tislelizumab combined with platinum-containing dual-drug regimen in elderly patients with advanced lung adenocarcinoma
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 1
Abstract
<b>Objective</b> To explore the efficacy of tislelizumab combined with pemetrexed and carboplatin chemotherapy in elderly patients with advanced lung adenocarcinoma and its effects on serum insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3) levels. <b>Methods</b> Ninety-four driver gene-negative elderly patients with advanced lung adenocarcinoma admitted to the Fourth Affiliated Hospital of Nanjing Medical University from July 2021 to December 2022 were selected as the study subjects. They were divided into chemotherapy group (pemetrexed combined with carboplatin, n=48) and tislelizumab group (pemetrexed+carboplatin+tislelizumab, n=46) by the random number table method, and both groups were treated for 4 cycles, with 21 days as a cycle. The clinical efficacy, immune function ［T lymphocyte subsets (CD4 <sup>+</sup>, CD8 <sup>+</sup>, CD4 <sup>+</sup>/CD8 <sup>+</sup>)］ and serum indicators (IGF-1, IGFBP-3) before and after treatment were recorded in both groups, and the adverse reactions were assessed. <b>Results</b> The clinical efficacy and objective response rate (58.70% vs 29.17%, χ<sup>2</sup>=8.329, P＜0.01) in tislelizumab group were significantly higher than those in chemotherapy group. After 4 cycles of treatment, the CD4 <sup>+</sup>, CD4 <sup>+</sup>/CD8 <sup>+</sup> and IGFBP-3 levels in both groups were significantly increased compared with those before treatment (P＜0.05), and the indicators in tislelizumab group were higher than those in chemotherapy group (P＜0.05); CD8 <sup>+</sup> and IGF-1 levels were significantly decreased in both groups compared with those before treatment (P＜0.05), and the indicators in tislelizumab group were lower than those in chemotherapy group (P＜0.05). Adverse reactions were mainly grade 1-2 in both groups, and there was no significant difference in the incidence of adverse reactions between two groups (P＞0.05). <b>Conclusion</b> The first-line therapy of tislelizumab combined with platinum-containing dual-drug for elderly advanced lung adenocarcinoma can improve the clinical efficacy, improve the balance of CD4 <sup>+</sup>/CD8 <sup>+</sup>, regulate the expression of serum IGF-1 and IGFBP-3 levels. The adverse reactions are controllable, and the treatment regimen is safe and reliable.
Authors and Affiliations
WANG Fei*, LIU Pei, PU Jiaze, YU Jun
Keywords
Related Articles
- EP ID EP735799
- DOI 10.13429/j.cnki.cjcr.2024.01.007
- Views 81
- Downloads 0
Safety and feasibility analysis of indocyanine green guided preservation of upper rectal vessels in laparoscopic radical resection of sigmoid cancer
Objective To investigate the safety and feasibility of indocyanine green guided preservation of the superior rectal artery in patients undergoing laparoscopic radical resection for sigmoid cancer. Methods A total of 73 p...
Visual analysis of domestic and international hotspots of nutritional research in children with tumors
<b>Objective</b> To analyze the literatures related to the nutrition of children with tumors at home and abroad, and sort out the current status, hotspots and frontiers of the research in this field, so as to provide a...
lncRNA ANCR regulating the effects of miR-497-5p on vascular lumen formation and apoptosis of gastric cancer cells
<b>Objective</b> To explore the effects of lncRNA ANCR regulating miR-497-5p on vascular lumen formation, apoptosis and PI3K/AKT signaling pathway of gastric cancer cells. <b>Methods</b> Gastric cancer cells were collect...
Research progress in ion channel mechanism of morphine addiction
Morphine is a classic opioid analgesic drug commonly used to treat chronic pain, cancer pain, neuropathic pain, etc. But repeated use can be addictive, this makes its clinical use severely limited. Morphine addiction has...
Application of peripheral nerve invasion based nomogram model in predicting the prognosis of stage Ⅰ-Ⅲ early-onset colorectal cancer
Objective To evaluate the impact of peripheral nerve aggression (PNI) on prognosis in patients with stage Ⅰ-Ⅲ early-onset colorectal cancer (EO-CRC) and to create a PNI-based nomogram prediction model. Methods This study...